
Journal of Organic Chemistry p. 4181 - 4187 (1990)
Update date:2022-08-05
Topics:
Kitas
Perich
Tregear
Johns
The phosphorylated derivative N(α)-(tert-butoxycarbonyl)-O-(dimethylphosphono)tyrosine anthraquinon-2-ylmethyl ester, Boc-Tyr(PO3Me2)-OMaq (2), was prepared in high yields by either phosphotriester or ''phosphite-triester'' phosphorylation of Boc-Tyr-OMaq (1). In the former case, either sodium hydride or lithium diisopropylamide was used to generate the phenoxide ion which was then treated with dimethyl phosphorochloridate (MeO)2P(O)Cl. Alternatively, dimethyl N,N-diethylphosphoramidite (MeO)2PNEt2 (15) and 1H-tetrazole were used in the phosphite-triester approach, to effect the quantitative, acid-catalyzed phosphitylation followed by m-chloroperoxybenzoic acid oxidation of the phosphite-triester intermediate. Removal of the 2-methylanthraquinone group (Maq) by reduction with sodium dithionite afforded Boc-Tyr(PO3Me2)-OH (3) in 70-75% overall yield. This derivative was used in the solution-phase synthesis of the tripeptide Boc-Pro-Tyr(PO3Me2)-Val-OMaq (9) by the Boc mode of peptide synthesis, which was followed by the removal of the Maq and Boc groups by successive dithionite reduction and 40% CF3CO2H/CH2Cl2 treatments respectively. Six procedures for the cleavage of the methyl phosphate group by acidolysis or silylolysis from H-Pro-Tyr(PO3Me2)-Val-OH·TFA (11) were examined with the source of hard acid being CF3SO3H, (CH3)3SiBr, (CH3)3SiBr, or CF3SO3Si(CH3)3 and either thioanisole or dimethyl sulfide as the soft nucleophile. While deprotection treatments gave H-Pro-Tyr(P)-Val-OH in modest isolated yields, monitoring with 31P NMR and 13C NMR indicated quantitative deprotection. Enhanced rates of methyl cleavage from the protecting phosphate group were observed with the use of thioanisole.
View MoreJintan Jinnuo Chemical Co., Ltd.
Contact:+86-519-80199901
Address:Room 1804, Building 1, Huacheng Business Plaza, Jintan, Jiangsu, China
website:http://www.acrospharmatech.com
Contact:+1-3234804688
Address:Flat/RM 1502,Easey Commercial building 253-261 Hennessy Road,Wanchai,HongKong
Jiangxi Huashi Pharmaceutical Co., Ltd
Contact:+86-795-4509628
Address:No.199, Ningbo Avenue, Fengxin industrial park, Fengxin county, Yichun city, Jiangxi
Hubei Honch Pharmaceutical Co.,Ltd
Contact:86-713-7222018
Address:Li Shizhen Pharmaceutical Industry park, Qichun County, Hubei Province,China
JIANGSU GRAND XINYI PHARMACEUTICAL CO.,LTD
website:http://www.xypharm.com/
Contact:+86-515-84383317
Address:Chenli Road,Costal Chemical Area Binhai,Yancheng, Jiangsu,China
Doi:10.1021/ol901744e
(2009)Doi:10.1016/j.bmcl.2009.07.005
(2009)Doi:10.1039/cc9960000201
(1996)Doi:10.1039/b007068h
(2001)Doi:10.1021/ol901704f
(2009)Doi:10.1016/j.carres.2009.04.019
(2009)